Workflow
氟吡菌酰胺原药
icon
Search documents
每天三分钟公告很轻松 | 平潭发展、海峡创新周五复牌;艾迪精密、航材股份拟回购股份
Core Points - Pingtan Development and Haixia Innovation have completed their suspension review and will resume trading on November 21, 2025 [1][2] - Eddy Precision and Hangcai Co. plan to repurchase shares [3] - Wenfeng Co.'s deputy general manager has been placed under investigation [4] - Kesi Co. has undergone a change in its actual controller [6][7] - Major events include the completion of restructuring investments by *ST Lian Shi and acquisitions by Jun Ting Hotel and Lek Electric [8][9] Group 1: Resumption of Trading - Pingtan Development's stock will resume trading on November 21, 2025, after confirming no significant changes in its operations or undisclosed major matters [1] - Haixia Innovation's stock will also resume trading on November 21, 2025, with similar confirmations regarding its operational status [2] Group 2: Share Repurchase Plans - Eddy Precision plans to repurchase shares with a total amount between 100 million and 200 million yuan, at a price not exceeding 27 yuan per share [3] - Hangcai Co. intends to repurchase shares using excess funds, with a total amount between 50 million and 100 million yuan, at a price not exceeding 80 yuan per share [3] Group 3: Investigations and Changes in Management - Wenfeng Co.'s deputy general manager, Qin Guofen, is under investigation, but the company states this will not significantly impact its operations [4] - Kesi Co. has changed its actual controller from Zhou Jiuqing and Zhou Xuming to Zhou Xuming alone following the death of Zhou Jiuqing [6][7] Group 4: Major Events - *ST Lian Shi has received a total of 1.238 billion yuan in restructuring investments from all investors [8] - Jun Ting Hotel has agreed to acquire the remaining 21% stake in Junlan Management for 79.8 million yuan, making it a wholly-owned subsidiary [9] - Lek Electric plans to transfer 90% of its subsidiary's equity to Chuangyuan Resources, with a target valuation of 235 million yuan [9]
利民股份(002734.SZ)子公司新型高效多功能植保原药技改项目取得环评批复
智通财经网· 2025-11-20 08:13
该批复同意利民化学在现有厂区内,建设新型高效多功能植保原药技改项目,项目建成后将形成年产 100吨氟吡菌酰胺原药产品生产能力。并且落实批复中提出的各项环保要求,确保污染物达标排放,严 格执行配套建设的环境保护设施与主体工程同时设计、同时施工、同时投产使用的环境保护"三同时"制 度。 利民股份(002734.SZ)公告,公司全资子公司利民化学有限责任公司(简称"利民化学")于近日收到江苏省 生态环境厅下发的《关于利民化学有限责任公司年产100吨新型高效多功能植保原药技改项目环境影响 报告书的批复》。 ...
利民股份子公司新型高效多功能植保原药技改项目取得环评批复
Zhi Tong Cai Jing· 2025-11-20 08:09
Core Viewpoint - Limin Co., Ltd. has received approval from the Jiangsu Provincial Department of Ecology and Environment for its subsidiary Limin Chemical's project to produce 100 tons of a new type of efficient multifunctional pesticide raw material annually [1] Group 1: Project Approval - The approval allows Limin Chemical to construct a new efficient multifunctional pesticide raw material project within its existing plant [1] - The project will have an annual production capacity of 100 tons of fluopyram raw material [1] Group 2: Environmental Compliance - The company is required to implement all environmental protection measures outlined in the approval to ensure pollutant emissions meet standards [1] - The project must adhere to the "three simultaneous" system, which mandates that environmental protection facilities are designed, constructed, and put into operation concurrently with the main project [1]